Sino Biopharmaceutical Statistics

Total Valuation

HKG:1177 has a market cap or net worth of HKD 68.71 billion. The enterprise value is 75.10 billion.

Market Cap	68.71B
Enterprise Value	75.10B

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jun 16, 2025

Share Statistics

HKG:1177 has 17.89 billion shares outstanding. The number of shares has decreased by -1.26% in one year.

Current Share Class	n/a
Shares Outstanding	17.89B
Shares Change (YoY)	-1.26%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	50.56%
Owned by Institutions (%)	18.13%
Float	8.85B

Valuation Ratios

The trailing PE ratio is 34.40 and the forward PE ratio is 20.39. HKG:1177's PEG ratio is 1.33.

PE Ratio	34.40
Forward PE	20.39
PS Ratio	2.24
PB Ratio	1.51
P/TBV Ratio	2.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.33

Financial Ratio History

Enterprise Valuation

EV / Earnings	20.16
EV / Sales	2.44
EV / EBITDA	11.78
EV / EBIT	13.97
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.

Current Ratio	1.26
Quick Ratio	1.02
Debt / Equity	0.23
Debt / EBITDA	1.60
Debt / FCF	n/a
Interest Coverage	17.51

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE)	11.82%
Return on Assets (ROA)	5.01%
Return on Invested Capital (ROIC)	6.25%
Return on Capital Employed (ROCE)	11.27%
Revenue Per Employee	1.26M
Profits Per Employee	152,772
Employee Count	24,379
Asset Turnover	0.45
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.78% in the last 52 weeks. The beta is 0.75, so HKG:1177's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+50.78%
50-Day Moving Average	3.51
200-Day Moving Average	3.28
Relative Strength Index (RSI)	62.27
Average Volume (20 Days)	116,823,338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1177 had revenue of HKD 30.72 billion and earned 3.72 billion in profits. Earnings per share was 0.20.

Revenue	30.72B
Gross Profit	25.04B
Operating Income	5.50B
Pretax Income	5.62B
Net Income	3.72B
EBITDA	6.50B
EBIT	5.50B
Earnings Per Share (EPS)	0.20

Full Income Statement

Balance Sheet

The company has 15.53 billion in cash and 10.41 billion in debt, giving a net cash position of 5.12 billion or 0.29 per share.

Cash & Cash Equivalents	15.53B
Total Debt	10.41B
Net Cash	5.12B
Net Cash Per Share	0.29
Equity (Book Value)	45.52B
Book Value Per Share	1.90
Working Capital	5.46B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 17.91% and 12.12%.

Gross Margin	81.51%
Operating Margin	17.91%
Pretax Margin	18.28%
Profit Margin	12.12%
EBITDA Margin	21.16%
EBIT Margin	17.91%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.09%.

Dividend Per Share	0.08
Dividend Yield	2.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.26%
Shareholder Yield	3.35%
Earnings Yield	5.42%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 20, 2020
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a